RLIP76: A versatile transporter and an emerging target for cancer therapy

Biochemical Pharmacology

Volumn 79, Issue 12, 2010, Pages 1699-1705

  Vatsyayan, Rit ^a   Lelsani, Poorna Chandra Rao ^a   Awasthi, Sanjay ^a   Singhal, Sharad S ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Cancer; Chemotherapy; Drug resistance; Radiation resistance; RLIP76; Xenografts

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTISENSE OLIGONUCLEOTIDE; CARRIER PROTEIN; CISPLATIN; COMPLEMENTARY DNA; DAUNORUBICIN; DOXORUBICIN; IMMUNOGLOBULIN G ANTIBODY; MELPHALAN; MITOMYCIN C; NAVELBINE; RAL INTERACTING PROTEIN; SMALL INTERFERING RNA; SORAFENIB; SUNITINIB; TRASTUZUMAB; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER INHIBITION; COLON CANCER; DRUG POTENTIATION; DRUG TARGETING; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; KIDNEY CANCER; LUNG CANCER; LUNG NON SMALL CELL CANCER; MELANOMA; MULTIDRUG RESISTANCE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RADIATION PROTECTION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; GTPASE-ACTIVATING PROTEINS; MICE; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 77951299314     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.01.016     Document Type: Note

References (55)

1. Awasthi S., Singhal S.S., Srivastava S.K., Zimniak P., Bajpai K.K., Saxena M., et al. Adenosine-triphosphate-dependent transport of doxorubicin, daunomyicn, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J Clin Invest 1994, 93:958-965.
2. LaBelle E.F., Singh S.V., Srivastava S.K., Awasthi Y.C. Dinitrophenyl glutathione efflux from human erythrocytes is primary active ATP-dependent transport. Biochem J 1986, 238:443-449.
3. 4 in cancer cells: implications in drug-resistance. Int J Cancer 2004, 112:934-942.
4. Quaroni A., Paul E.C. Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic-apparatus. J Cell Sci 1999, 112:707-718.
5. Cheng J., Sharma R., Yang Y., Singhal S.S., Sharma A., Saini M.K., et al. Accelerated metabolism and exclusion of 4-hydroxy-nonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative-stress. J Biol Chem 2001, 276:41213-41223.
6. Awasthi S., Singhal S.S., Yadav S., Singhal J., Drake K., Nadkar A., et al. RLIP76 is a major determinant of radiation-sensitivity. Cancer Res 2005, 65:6022-6028.
7. Singhal J., Singhal S.S., Yadav S., Warnke M., Yacoub A., Dent P., et al. RLIP76 in defense of radiation and chemical-poisoning. Int J Rad Oncol Biol Phys 2008, 72:553-561.
8. Singhal S.S., Awasthi Y.C., Awasthi S. Regression of melanoma in a murine model by RLIP76-depletion. Cancer Res 2006, 66:2354-2360.
9. Singhal S.S., Singhal J., Yadav S., Dwivedi S., Boor P., Awasthi Y.C., et al. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76. Cancer Res 2007, 67:4382-4389.
10. Singhal S.S., Singhal J., Yadav S., Sahu M., Awasthi Y.C., Awasthi S. RLIP76: a target for kidney cancer therapy. Cancer Res 2009, 69:4244-4251.
11. Singhal S.S., Roth C., Leake K., Singhal J., Yadav S., Awasthi S. Regression of prostate cancer xenografts by RLIP76 depletion. Biochem Pharmacol 2009, 77:1074-1083.
12. Jullien-Flores V., Dorseuil O., Romero F., Letourneur F., Saragosti S., Berger R., et al. Bridging Ral-GTPase to Rho-pathways. RLIP76, a Ral-effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem 1995, 270:22473-22477.
13. Awasthi S., Cheng J., Singhal S.S., Saini M.K., Pandya U., Pikula S., et al. Novel function of human RLIP76: ATP-dependent transport of glutathione-conjugates and doxorubicin. Biochemistry 2000, 39:9327-9334.
14. Awasthi S., Cheng J., Singhal S.S., Sharma R., Pandya U., Singh S.V., et al. Functional reassembly of xenobiotic-transport from the N-terminal and C-terminal domains of RLIP76 and identification of ATP-binding sequences. Biochemistry 2001, 40:4159-4168.
15. Awasthi S., Singhal S.S., Sharma R., Zimniak P., Awasthi Y.C. Transport of glutathione-conjugates and chemotherapeutic drugs by RLIP76: a novel link between G-protein and tyrosine-kinase signaling and drug-resistance. Int J Cancer 2003, 106:635-646.
16. Awasthi Y.C., Sharma R., Yadav S., Dwivedi S., Sharma A., Awasthi S. The non-ABC drug-transporter RLIP76 plays a major role in the mechanisms of drug-resistance. Curr Drug Metab 2007, 8:315-323.
17. Yadav S., Zajac E., Singhal S.S., Awasthi S. Linking stress-signaling, glutathione-metabolism, signaling pathways and xenobiotic-transporters. Cancer Metas Rev 2007, 26:59-69.
18. Awasthi S., Sharma R., Singhal S.S., Zimniak P., Awasthi Y.C. RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics. Drug Metab Dispos 2002, 30:1300-1310.
19. Hu Y., Mivechi N.F. HSF-1 interacts with Ral-binding-protein 1 in a stress-responsive, multi-protein complex with HSP90 in vivo. J Biol Chem 2003, 278:17299-17306.
20. Singhal S.S., Yadav S., Drake K., Singhal J., Awasthi S. Hsf-1 and POB1 induce drug-sensitivity and apoptosis by inhibiting Ralbp1. J Biol Chem 2008, 283:19714-19729.
21. Sharma R., Gupta S., Singh S.V., Medh R.D., Ahmad H., LaBelle E.F., et al. Purification and characterization of dinitrophenylglutathione ATPase of human erythrocytes and its expression in other tissues. Biochem Biophys Res Commun 1990, 171:155-161.
22. Awasthi S., Singhal S.S., Srivastava S.K., Torman R.T., Zimniak P., Pikula J., et al. ATP dependent human erythrocyte glutathione-conjugate-transporter. I. Purification, photoaffinity-labeling, and kinetic characteristics of ATPase-activity. Biochemistry 1998, 37:5231-5238.
23. Awasthi S., Singhal S.S., Pikula S., Piper J.T., Srivastava S.K., Torman R.T., et al. ATP-dependent human erythrocyte glutathione-conjugate-transporter. II. Functional reconstitution of transport-activity. Biochemistry 1998, 37:5239-5248.
24. Cantor S.B., Urano T., Feig L.A. Identification and characterization of Ral-binding-protein1, a potential downstream target of Ral GTPases. Mol Cell Biol 1995, 15:4578-4584.
25. Park S.H., Weinberg R.A. A putative effector of Ral has homology to Rho/Rac GTPase-activating proteins. Oncogene 1995, 11:2349-2355.
26. Singhal S.S., Awasthi S. Glutathione-conjugate transport and stress-response signaling: role of RLIP76. Toxicology of glutathione S-transferases 2006, CRC Press, Boca Raton, FL, p. 231-56.
27. Rosse C., L'Hoste S., Offner N., Picard A., Camonis J.H. RLIP, an effector of the Ral-GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J Biol Chem 2003, 278:30597-30604.
28. Singhal S.S., Yadav S., Vatsyayan R., Chaudhary P., Borvak J., Singhal J., et al. Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis. Cancer Lett 2009, 283:152-158.
29. Yadav S., Zajac E., Singhal S.S., Singhal J., Drake K., Awasthi Y.C., et al. POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis. Biochem Biophys Res Commun 2005, 328:1003-1009.
30. Oosterhoff J.K., Penninkhof F., Brinkmann A.O., Grootegoed J.A., Blok L.G. POB1 is down-regulated during human prostate cancer progression and inhibits growth factor signaling in prostate cancer cells. Oncogene 2003, 22:2920-2925.
31. Awasthi S., Hallene K.L., Fazio V., Singhal S.S., Cucullo L., Awasthi Y.C., et al. RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci 2005, 6:61.
32. Stuckler D., Singhal J., Singhal S.S., Yadav S., Awasthi Y.C., Awasthi S. RLIP76 transports vinorelbine and mediates drug-resistance in non-small cell lung cancer. Cancer Res 2005, 65:991-998.
33. Awasthi S., Singhal S.S., Pandya U., Gopal S., Zimniak P., Singh S.V., et al. ATP-dependent colchicines transport by human erythrocyte glutathione-conjugate-transporter. Toxicol Appl Pharmacol 1999, 155:215-226.
34. Singhal S.S., Sehrawat A., Sahu M., Singhal P., Vatsyayan R., Lelsani P.C., et al. RLIP76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. Int J Cancer 2010, 126:1327-1338.
35. Awasthi S., Singhal S.S., Singhal J., Cheng J., Zimniak P., Awasthi Y.C. Role of RLIP76 in lung cancer doxorubicin-resistance. II. Doxorubicin-transport in lung cancer by RLIP76. Int J Oncol 2003, 22:713-720.
36. Singhal S.S., Yadav S., Singhal J., Sahu M., Sehrawat A., Awasthi S. Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76. FEBS Lett 2008, 582:3408-3414.
37. Singhal S.S., Yadav S., Singhal J., Zajac E., Awasthi Y.C., Awasthi S. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin. Biochem Pharmacol 2005, 70:481-488.
38. Singhal S.S., Singhal J., Sharma R., Singh S.V., Zimniak P., Awasthi Y.C., et al. Role of RLIP76 in lung cancer doxorubicin-resistance. I. The ATPase activity of RLIP76 correlates with doxorubicin and 4HNE-resistance in lung cancer cells. Int J Oncol 2003, 22:365-375.
39. Sharma R., Singhal S.S., Cheng J., Yang Y., Sharma A., Zimniak P., et al. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes. Arch Biochem Biophys 2001, 391:171-179.
40. Singhal S.S., Wickramarachchi D., Singhal J., Yadav S., Awasthi Y.C., Awasthi S. Determinants of differential doxorubicin-sensitivity between SCLC and NSCLC. FEBS Lett. 2006, 580:2258-2264.
41. Singhal S.S., Yadav S., Singhal J., Awasthi Y.C., Awasthi S. Mitogenic and drug-resistance mediating effects of PKCα require RLIP76. Biochem Biophys Res Commun 2006, 348:722-727.
42. Singhal S.S., Yadav S., Singhal J., Drake K., Awasthi Y.C., Awasthi S. The role of PKCα and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer. FEBS Lett 2005, 579:4635-4641.
43. Awasthi S., Singhal S.S., Singhal J., Yang Y., Zimniak P., Awasthi Y.C. Role of RLIP76 in lung cancer doxorubicin-resistance. III. Anti-RLIP76-antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin-cytotoxicity. Int J Oncol 2003, 22:721-732.
44. Goldfinger L.E., Ptak C., Jeffery E.D., Shabanowitz J., Hunt D.F., Ginsberg M.H. RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac-activation and cell migration. J Cell Biol 2006, 174:877-888.
45. Yadav S., Singhal S.S., Singhal J., Wickramarachchi D., Kuntson E., Albrecht T.B., et al. Identification of membrane-anchoring domains of RLIP76 using deletion mutants analyses. Biochemistry 2004, 43:16243-16253.
46. Choudhuri S., Klaassen C.D. Structure, function, expression, genomic organization, and single nucleotide-polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux-transporters. Int J Toxicol 2006, 25:231-259.
47. Higgins C.F. Multiple molecular mechanisms for multidrug-resistance transporters. Nature 2007, 446:749-757.
48. Sharom F.J. ABC multidrug-transporters: structure, function and role in chemo-resistance. Pharmacogenomics 2008, 9:105-127.
49. Paumi C.M., Ledford B.G., Smitherman P.K., Townsend A.J., Morrow C.S. Role of multi-drug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity. J Biol Chem 2001, 276:7952-7956.
50. Drake K.J., Singhal J., Yadav S., Nadkar A., Singhal S.S., Awasthi S. RALBP1/RLIP76 mediates multi-drug resistance. Int J Oncol 2007, 30:139-144.
51. Singhal S.S., Sehrawat A., Mehta A., Sahu M., Awasthi S. Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugate. Int J Oncol 2009, 34:191-199.
52. Herlevsen M.C., Theodorescu D. Mass spectroscopic phosphoprotein mapping of Ral-binding-protein1 (RalBP1/Rip1/RLIP76). Biochem Biophys Res Commun 2007, 362:56-62.
53. Margutti P., Matarrese P., Conti F., Colasanti T., Delunardo F., Capozzi A., et al. Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative-stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood 2008, 111:4559-4570.
54. Leschziner G.D., Jorgensen A.L., Andrew T., Williamson P.R., Marson A.G., Coffey A.J., et al. The association between polymorphisms in RLIP76 and drug-response in epilepsy. Pharmacogenomics 2007, 8:1715-1722.
55. American Cancer Society. 2009 Cancer facts and figures. http://www.cancer.org/downloads/STT/500809web.pdf.